: Debt-limit deal is a blow to public health, experts say 

Spending caps and clawbacks of COVID-relief money are seen crimping investments in research and disease surveillance.

Previous post Help My Career: CDC says sick leave can prevent food poisoning — yet a paltry number of food workers get paid leave
Next post The Ratings Game: Chevron’s ‘defensive characteristics’ make it well-positioned for economic uncertainty, JPMorgan says